Last Posted: Aug 09, 2018
- Combinatorial pharmacogenomics and improved patient outcomes in depression: Treatment by primary care physicians or psychiatrists.
Tanner Julie-Anne et al. Journal of psychiatric research 2018 Jul 104157-162 - How the evidence stacks up for preventing Alzheimer’s disease
E Sohn, Nature Outlook, July 2018 - Pharmacogenomics and the Future of Pharmacy
J Sederstrom, Drug Topics, July 2018 - The Road to There`
C Herrera, American Heart Association Blog, July 16, 2018 - DNA Methylation Signatures of Depressive Symptoms in Middle-aged and Elderly Persons: Meta-analysis of Multiethnic Epigenome-wide Studies.
Story Jovanova Olivera et al. JAMA psychiatry 2018 Jul - Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Information for Healthcare Providers - A Conceptual Model of Angelman Syndrome and Review of Relevant Clinical Outcomes Assessments (COAs).
Grieco Joseph C et al. The patient 2018 Jul - Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder.
Zastrozhin Mikhail Sergeevich et al. Pharmacogenomics and personalized medicine 2018 11113-119 - New Genetic Links to Depression May Pave the Way for Novel Treatment Strategies.
Hampton Tracy et al. JAMA 2018 Jul 320(1) 20-21 - New Genetic Links to Depression May Pave the Way for Novel Treatment Strategies
T Hampton, JAMA, July 3, 2018
No hay comentarios:
Publicar un comentario